Beijing Tongrentang Co., Ltd
Shanghai Stock Exchange 600085.SS
Beijing Tongrentang Co., Ltd Operating Cash Flow for the year ending December 31, 2023: USD 263.32 M
-
Beijing Tongrentang Co., Ltd Operating Cash Flow for the year ending December 31, 2022 was USD 448.39 M, a -16.85% change year over year.
-
Beijing Tongrentang Co., Ltd Operating Cash Flow for the year ending December 31, 2021 was USD 539.25 M, a 61.86% change year over year.
-
Beijing Tongrentang Co., Ltd Operating Cash Flow for the year ending December 31, 2020 was USD 333.15 M, a 2.04% change year over year.
-
Beijing Tongrentang Co., Ltd Operating Cash Flow for the year ending December 31, 2019 was USD 326.50 M, a 16.45% change year over year.
| Date | Operating Cash Flow | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities | Dividends Paid |
|---|
| CEO | Ms. Chaohua Zhang |
| IPO Date | June 25, 1997 |
| Location | China |
| Headquarters | No. 42 Chongwenmenwai Street |
| Employees | 16,777 |
| Sector | Health Care |
| Industries | |
Beijing Tongrentang Co., Ltd engages in the scientific research, production, sale, and distribution of Chinese medicines in China and internationally. It covers product formulations, such as pills, powders, wines and capsules, oral liquids, and dripping pills with the original powder preparation in the areas of cardiovascular, cerebrovascular, and gynecological diseases, as well as anti-depressive new drugs. The company sells its products under the brand names of Angong Niuhuang series, Tongren Niuhuang Qingxin series, Tongren Dahuoluo series, Yufeng Ningxin dripping pills, Hemiplegia recovery pills, etc. The company is based in Beijing, China. Beijing Tongrentang Co., Ltd operates as a subsidiary of China Beijing Tongrentang (Group) Co., Ltd.
Past 5 years
USD 0.78
USD 7.83
USD 4.53
StockViz Staff
January 15, 2025
Any question? Send us an email